Cardinal Health Reports 14.3% Revenue Growth to $254.2 Billion for Fiscal Year 2026

Cardinal Health, Inc. reported a significant increase in its financial performance for the fiscal year ending June 30, 2026, with total revenue reaching $254.2 billion, up from $222.6 billion in the previous year, marking a 14.3% increase. The company's operating earnings also rose to $2.6 billion, a 15% increase from $2.3 billion in fiscal 2025. Net earnings attributable to Cardinal Health increased to $1.7 billion, or $7.23 per diluted share, compared to $1.6 billion, or $6.45 per diluted share, in the prior year. This growth was driven by strong performance in both the Pharmaceutical and Specialty Solutions segment, which generated $234.8 billion in revenue, and the Global Medical Products and Distribution segment, which contributed $12.7 billion.

The fiscal year saw Cardinal Health undertake several strategic acquisitions, including the purchase of Solaris Health for approximately $1.9 billion, Advanced Diabetes Supply for $1 billion, and a 73% stake in GI Alliance for $2.8 billion. These acquisitions are expected to enhance the company's capabilities in specialty healthcare services and expand its market presence. Additionally, Cardinal Health's partnership with CVS Health through Red Oak Sourcing continues to streamline its generic pharmaceutical supply chain, further solidifying its competitive position in the market.

Operationally, Cardinal Health reported a total employee headcount of approximately 63,900 as of June 30, 2026, with 37,000 employees working in distribution centers and manufacturing facilities. The company also noted a significant reliance on CVS Health, which accounted for 28% of its total revenue, highlighting the concentration of its customer base. The company’s inventory management practices, including a LIFO inventory valuation method, have been effective in managing costs, with total inventories reported at $17.3 billion.

Looking ahead, Cardinal Health anticipates continued growth driven by its strategic investments and acquisitions, although it acknowledges potential challenges from regulatory changes and market dynamics. The company is focused on enhancing operational efficiencies and expanding its service offerings to meet evolving healthcare demands. The management expressed confidence in achieving its long-term financial goals, despite the complexities of the healthcare landscape and ongoing legal matters related to opioid litigation.